Abstract
Purpose
The association of dietary advanced glycation endproducts (AGEs) intake with the oxidative and inflammatory status in type 2 diabetic patients was examined.
Methods
Seventy-four healthy controls, 50 low AGEs intake and 68 high AGEs intake type 2 diabetic patients were requested to complete a 7-day dietary record. Blood levels of several oxidative and inflammatory biomarkers were determined.
Results
Diabetic patients with high AGEs intake had significantly elevated plasma levels of AGEs, HbA1c, low-density lipoprotein (LDL), LDL-cholesterol and glycated LDL than low AGEs intake patients and controls (P < 0.05). These high AGEs intake patients also had significantly increased plasma levels of 8-isoprostane, interleukin (IL)-1α, tumor necrosis factor-α, monocyte chemoattractant protein (MCP)-1 and lower superoxide dismutase (SOD) activity than low AGEs intake patients (P < 0.05). Correlation coefficients of dietary AGEs versus plasma AGEs, HbA1c, 8-isoprostane, IL-1α and MCP-1 were >0.6; but the correlation coefficient of dietary AGEs versus plasma SOD activity was <−0.6.
Conclusion
Increasing dietary AGEs intake might enrich circulating AGE level and contribute to oxidative and inflammatory progression under diabetic condition. The circulating 8-isoprostane, IL-1α and MCP-1 levels and SOD activity might be appropriate biomarkers used to evaluate dietary AGEs-associated oxidative and inflammatory stress.
Similar content being viewed by others
References
Koschinsky T, He CJ, Mitsuhashi T, Bucala R, Liu C, Buenting C, Heitmann K, Vlassara H (1997) Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci USA 94:6474–6479
Riviere S, Birlouez-Aragon I, Vellas B (1998) Plasma protein glycation in Alzheimer’s disease. Glycoconj J 15:1039–1042
Vlassara H, Cai W, Crandall J, Goldberg T, Oberstein R, Dardaine V, Peppa M, Rayfield EJ (2002) Inflammatory markers are induced by dietary glycotoxins: a major risk factor for diabetic angiopathy. Proc Natl Acad Sci USA 99:15596–15601
Negrean M, Stirban A, Stratmann B, Gawlowski T, Horstmann T, Götting C, Kleesiek K, Mueller-Roesel M, Koschinsky T, Uribarri J, Vlassara H, Tschoepe D (2007) Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr 85:1236–1243
Uribarri J, Stirban A, Sander D, Cai W, Negrean M, Buenting CE, Koschinsky T, Vlassara H (2007) Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects. Diabetes Care 30:2579–2582
Stirban A, Negrean M, Götting C, Uribarri J, Gawlowski T, Stratmann B, Kleesiek K, Koschinsky T, Vlassara H, Tschoepe D (2008) Dietary advanced glycation endproducts and oxidative stress: in vivo effects on endothelial function and adipokines. Ann N Y Acad Sci 1126:276–279
Erbersdobler HF, Somoza V (2007) Forty years of furosine—forty years of using Maillard reaction products as indicators of the nutritional quality of foods. Mol Nutr Food Res 51:423–430
Goldberg T, Cai W, Melpomeni P, Dardaine V, Baliga BS, Uribarri J, Vlassara H (2004) Advanced glycoxidation end products in commonly consumed foods. J Am Diet Ass 104:1287–1291
Chao PC, Hsu CC, Yin MC (2009) Analysis of glycative products in sauces and sauce-treated foods. Food Chem 113:262–266
Department of Health (1998) Taiwan nutrient databases 1998. Department of Health, Executive Yuan, Taipei, Taiwan
Shea J, Randell E, Vasdev S, Wang PP, Roebothan B, Sun G (2007) Serum retinol-binding protein 4 concentrations in response to short-term overfeeding in normal-weight, overweight, and obese men. Am J Clin Nutr 86:1310–1315
Hsu CC, Huang CN, Hung YC, Yin MC (2004) Five cysteine-containing compounds have antioxidative activity in Balb/cA mice. J Nutr 134:149–152
Konishi M, Iwasa M, Araki J, Kobayashi Y, Katsuki A, Sumida Y, Nakagawa N, Kojima Y, Watanabe S, Adachi Y, Kaito M (2006) Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane. J Gastroenterol Hepatol 21:1821–1825
Miyata T, Taneda S, Kawai R, Ueda Y, Horiuchi S, Hara M, Maeda K, Monnier VM (1996) Identification of pentosidine as a native structure for advanced glycation end products in β2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci USA 93:2353–2358
Wu Y, Monnier V, Friedlander M (1995) Reliable determination of furosine in human serum and dialysate proteins by high-performance liquid chromatography. J Chromatogr B 667:328–332
Nourooz-Zadeh J, Tajaddini-Sarmadi J, Ling KL, Wolff SP (1996) Low-density lipoprotein is the major carrier of lipid hydroperoxides in plasma. Biochem J 313:781–786
Duell PB, Oram JF, Biermann EL (1990) Nonenzymatic glycation of HDL resulting in inhibition of high-affinity binding to cultured human fibroblasts. Diabetes 39:1257–1263
Ahmed N (2005) Advanced glycation endproducts–role in pathology of diabetic complications. Diabetes Res Clin Pract 67:3–21
Miyata T, Izuhara Y (2008) Inhibition of advanced glycation end products: an implicit goal in clinical medicine for the treatment of diabetic nephropathy? Ann N Y Acad Sci 1126:141–146
Navarro-González JF, Milena FJ, Mora C, León C, García J (2006) Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotension-converting enzyme inhibition and pentoxifylline administration. Am J Nephrol 26:562–570
Demircan N, Safran BG, Soylu M, Ozcan AA, Sizmaz S (2006) Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye 20:1366–1369
Martinovic I, Abegunewardene N, Seul M, Vosseler M, Horstick G, Buerke M, Darius H, Lindemann S (2005) Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Circulation J 69:1484–1489
Kreisberg RA (1998) Diabetic dyslipidemia. Am J Cardiol 82:67–73
James PE, Lang D, Tufnell-Barret T, Milsom AB, Frenneaux MP (2004) Vasorelaxation by red blood cells and impairment in diabetes: reduced nitric oxide and oxygen delivery by glycated hemoglobin. Circ Res 94:976–983
Veiraiah A (2005) Hyperglycemia, lipoprotein glycation and vascular disease. Angiology 56:431–438
Isoda K, Folco E, Marwali MR, Ohsuzu F, Libby P (2008) Glycated LDL increases monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated chemotaxis. Atherosclerosis 198:307–312
Cipriani R, Sensi M, Gabriele A, Gatti A, Mandosi E, Di Mario U, Morano S (2004) The impairment of renal function is not associated to altered circulating vascular endothelial growth factor in patients with type 2 diabetes and hypertension. Diabetes Nutr Metab 17:90–94
Acknowledgments
All authors would like to thank all subjects participated in this study.
Conflict of interest
None of the authors reports a conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chao, Pc., Huang, Cn., Hsu, Cc. et al. Association of dietary AGEs with circulating AGEs, glycated LDL, IL-1α and MCP-1 levels in type 2 diabetic patients. Eur J Nutr 49, 429–434 (2010). https://doi.org/10.1007/s00394-010-0101-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-010-0101-3